181 related articles for article (PubMed ID: 26104840)
1. Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia.
Colado-Velázquez J; Mailloux-Salinas P; Medina-Contreras J; Cruz-Robles D; Bravo G
Phytother Res; 2015 Oct; 29(10):1525-31. PubMed ID: 26104840
[TBL] [Abstract][Full Text] [Related]
2. The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth.
Altavilla D; Bitto A; Polito F; Irrera N; Marini H; Arena S; Favilla V; Squadrito F; Morgia G; Minutoli L
J Urol; 2011 Oct; 186(4):1524-9. PubMed ID: 21855911
[TBL] [Abstract][Full Text] [Related]
3. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
Squadrito F; Morgia G
Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
[TBL] [Abstract][Full Text] [Related]
4. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
5. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
[TBL] [Abstract][Full Text] [Related]
6. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action.
Buck AC
J Urol; 2004 Nov; 172(5 Pt 1):1792-9. PubMed ID: 15540722
[TBL] [Abstract][Full Text] [Related]
7. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
Plosker GL; Brogden RN
Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
[TBL] [Abstract][Full Text] [Related]
8. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
9. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
Minutoli L; Bitto A; Squadrito F; Marini H; Irrera N; Morgia G; Passantino A; Altavilla D
Curr Med Chem; 2013; 20(10):1306-12. PubMed ID: 23432584
[TBL] [Abstract][Full Text] [Related]
10. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
Mantovani F
Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
[TBL] [Abstract][Full Text] [Related]
11. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
[TBL] [Abstract][Full Text] [Related]
12. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
[TBL] [Abstract][Full Text] [Related]
13. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
14. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
[TBL] [Abstract][Full Text] [Related]
15. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
[TBL] [Abstract][Full Text] [Related]
16. The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens.
Giannakopoulos X; Baltogiannis D; Giannakis D; Tasos A; Sofikitis N; Charalabopoulos K; Evangelou A
Adv Ther; 2002; 19(6):285-96. PubMed ID: 12665049
[TBL] [Abstract][Full Text] [Related]
17. Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat.
Paubert-Braquet M; Richardson FO; Servent-Saez N; Gordon WC; Monge MC; Bazan NG; Authie D; Braquet P
Pharmacol Res; 1996; 34(3-4):171-9. PubMed ID: 9051712
[TBL] [Abstract][Full Text] [Related]
18. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gerber GS; Fitzpatrick JM
BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia.
Bernichtein S; Pigat N; Camparo P; Latil A; Viltard M; Friedlander G; Goffin V
Prostate; 2015 May; 75(7):706-22. PubMed ID: 25683150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
